The Second International Workshop on the Evaluation and Management of Hypoparathyroidism.
Published in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Excess in growth hormone (GH) levels, seen in patients with acromegaly, is associated with increases in fractures. This happens despite wider bones and independent of bone mineral density. We used the bovine GH (bGH) transgenic mice, which show constitutive excess in GH and insulin-like growth factor 1 (IGF-1) in serum and tissues, to study how lif...
Published in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Osteoporosis affects over 200 million women worldwide, one-third of whom are predicted to suffer from an osteoporotic fracture in their lifetime. The most promising anabolic drugs involve administration of expensive antibodies. Because mechanical loading stimulates bone formation, our current data, using a mouse model, replicates the anabolic effec...
Published in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Both medical and surgical therapy represent potential management options for patients with asymptomatic primary hyperparathyroidism (PHPT). Because uncertainty remains regarding both medical and surgical therapy, this systematic review addresses the efficacy and safety of medical therapy in asymptomatic patients or symptomatic patients who decline ...
Published in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Fibrodysplasia ossificans progressiva (FOP) is a devastating disease of progressive heterotopic bone formation for which effective treatments are currently unavailable. FOP is caused by dominant gain-of-function mutations in the receptor ACVR1 (also known as ALK2), which render the receptor inappropriately responsive to activin ligands. In previous...
Published in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Opioid use is detrimental to bone health, causing both indirect and direct effects on bone turnover. Although the mechanisms of these effects are not entirely clear, recent studies have linked chronic opioid use to alterations in circulating miRNAs. Here, we developed a model of opioid-induced bone loss to understand bone turnover and identify cand...
Published in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Type 2 diabetes (T2D) is associated with increased risk of fractures. However, it is unclear whether current osteoporosis treatments reduce fractures in individuals with diabetes. The aim of the study was to determine whether presence of T2D influences the efficacy of antiresorptive treatment for osteoporosis using the Foundation for the National I...
Published in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Low bone mineral density (BMD) is suggested to be associated with increased mortality in the general health population, but the relationship in chronic kidney disease (CKD) patients is still unclear. We performed a meta-analysis to investigate the association of BMD in different sites with risk of all-cause mortality in CKD patients. We searched Pu...
Published in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Metabolic bone disease is a devastating condition in critically ill patients admitted to an intensive care unit (ICU). We investigated the effects of early administration of the antiresorptive drug denosumab on bone metabolism in previously healthy patients. Fourteen patients with severe intracerebral or subarachnoid hemorrhage were included in a p...